Hadi Kalantar
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection 9
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation 10
-
- Nigella sativa pharmacological applications 5
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 9
-
- Genomics, phytochemicals, and oxidative stress 3
-
- Arsenic contamination and mitigation 3
-
- Heavy Metal Exposure and Toxicity 3
-
- Acute Lymphoblastic Leukemia research 3
-
- Paraquat toxicity studies and treatments 3
- Co-authors
- Mehdi GoudarziMojtaba KalantarMohammad Javad KhodayarHeibatullah KalantariLayasadat KhorsandiEsrafil MansouriMahdi EsmaeilizadehIman Fatemi
- Journals
- SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)Archives of Biochemistry and Biophysics (1 paper)
In The Last Decade
Hadi Kalantar
33 papers receiving 642 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 167
- Pathology and Forensic Medicine 163
- Complementary and alternative medicine 62
- Drug Discovery 1
- Pharmacology 99
Countries citing papers authored by Hadi Kalantar
This map shows the geographic impact of Hadi Kalantar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadi Kalantar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadi Kalantar more than expected).
Fields of papers citing papers by Hadi Kalantar
This network shows the impact of papers produced by Hadi Kalantar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadi Kalantar. The network helps show where Hadi Kalantar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hadi Kalantar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 28 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 27 | |
| 12 | Alleviation of Liver Dysfunction, Oxidative Stress and Inflammation Underlies the Protective Effect of Ferulic Acid in Methotrexate-Induced Hepatotoxicity | 2020 | 0 |
| 13 | 2020 | 52 | |
| 14 | 2019 | 53 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 61 | |
| 17 | 2017 | 23 | |
| 18 | 2016 | 7 | |
| 19 | Apoptotic effect of Capparis Spinosa extract on breast cancer cell line (MCF-7) | 2016 | 1 |
| 20 | 2012 | 2 |
About Hadi Kalantar
Hadi Kalantar is a scholar working on Pharmacology, Complementary and alternative medicine and Molecular Medicine, having authored 35 papers that have together received 649 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers), Nigella sativa pharmacological applications (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Arsenic contamination and mitigation (3 papers), Heavy Metal Exposure and Toxicity (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Paraquat toxicity studies and treatments (3 papers). The work is most often cited by research in Pharmacology (167 citations), Pathology and Forensic Medicine (163 citations) and Complementary and alternative medicine (62 citations). Hadi Kalantar has collaborated with scholars based in Iran, Germany and Canada. Frequent co-authors include Mehdi Goudarzi, Mojtaba Kalantar, Mohammad Javad Khodayar, Heibatullah Kalantari, Layasadat Khorsandi, Esrafil Mansouri, Mahdi Esmaeilizadeh, Iman Fatemi, Habib Ghaznavi and Saeed Mehrzadi. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.